logo
  • Home
  • News
Menu

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

Home / Stock Analysis / GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A
Article feature image

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

12 Aug Stock Analysis

YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma (006280.KS) today announced the approval of GreenGene F (Beroctocog alfa)

Click here to view the original article.

Tags:
Business Wire, Global
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

RQO-CA_LONG_lineChartGenerator_2025-05-19_06-22-56.png
+

(RQO) Stock Analysis and Trading Signals

19 May Stock Analysis
stock_1747628304835_1747628305060.jpg
+

Protean eGov share price hits 20% lower circuit after govt rejects application for PAN 2.0 project

19 May Stock Analysis

recent post

  • RICH-MINER-34-1.jpg

    4 Groundbreaking Cryptos Poised For Explosive

    May 19 2025
  • RQO-CA_LONG_lineChartGenerator_2025-05-19_06-22-56.png

    (RQO) Stock Analysis and Trading Signals

    May 19 2025
  • 9981d64cb02866303a02fc88a783b7451718785990798402_original.jpg

    Bitcoin Bulls Eye Breakout As Volatility

    May 19 2025
  • 30e01e9a-7547-4528-a5cd-a76cbb5bbd69.png

    Thunderpick Picked as the Best

    May 19 2025
  • Big20Ben20and20the20House20of20Parliament20in20London2028shutterstock29_id_0b5b94ac-7975.jpeg

    UK Crypto Firms Will Need to

    May 19 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.